Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 439 | $169,550,102 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
21 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 20 Mar 2024 | Sale | 2,290 | 234.3304 | 536,617 | D |
21 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 19 Mar 2024 | Sale | 1,653 | 239.2995 | 395,562 | D |
21 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 19 Mar 2024 | Sale | 2,825 | 238.4828 | 673,714 | D |
21 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 19 Mar 2024 | Sale | 2,958 | 236.2809 | 698,919 | D |
21 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 19 Mar 2024 | Sale | 2,953 | 237.081 | 700,100 | D |
21 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 19 Mar 2024 | Sale | 2,409 | 235.0768 | 566,300 | D |
21 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 19 Mar 2024 | Sale | 975 | 233.9779 | 228,128 | D |
21 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 19 Mar 2024 | Sale | 1,227 | 233.2509 | 286,199 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 18 Mar 2024 | Sale | 154 | 235.91 | 36,330 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 18 Mar 2024 | Sale | 6,627 | 235.0471 | 1,557,657 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 18 Mar 2024 | Sale | 5,574 | 234.3115 | 1,306,052 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 18 Mar 2024 | Sale | 1,037 | 233.0812 | 241,705 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 18 Mar 2024 | Sale | 659 | 232.1344 | 152,977 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 18 Mar 2024 | Sale | 949 | 230.5909 | 218,831 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 15 Mar 2024 | Sale | 597 | 238.6844 | 142,495 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 15 Mar 2024 | Sale | 5,789 | 237.5755 | 1,375,325 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 15 Mar 2024 | Sale | 4,449 | 236.7662 | 1,053,373 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 15 Mar 2024 | Sale | 4,165 | 235.631 | 981,403 | D |
18 Aug 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 17 Aug 2023 | Sale | 1,601 | 231.2343 | 370,206 | D |
18 Aug 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 17 Aug 2023 | Sale | 1,100 | 230.2515 | 253,277 | D |
18 Aug 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 17 Aug 2023 | Sale | 1,400 | 229.4056 | 321,168 | D |
18 Aug 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 17 Aug 2023 | Sale | 1,899 | 227.8117 | 432,614 | D |
04 Aug 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 03 Aug 2023 | Sale | 300 | 243.13 | 72,939 | D |
04 Aug 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 03 Aug 2023 | Sale | 1,000 | 241.611 | 241,611 | D |
04 Aug 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 03 Aug 2023 | Sale | 400 | 239.9875 | 95,995 | D |
04 Aug 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 03 Aug 2023 | Sale | 300 | 238.3933 | 71,518 | D |
04 Aug 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 03 Aug 2023 | Sale | 600 | 236.8764 | 142,126 | D |
04 Aug 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 03 Aug 2023 | Sale | 1,259 | 232.9592 | 293,296 | D |
04 Aug 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 03 Aug 2023 | Sale | 2,141 | 233.529 | 499,986 | D |
24 Jul 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 20 Jul 2023 | Sale | 2,500 | 243.87 | 609,675 | D |
01 Jun 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 01 Jun 2023 | Sale | 2,850 | 209.7153 | 597,689 | D |
01 Jun 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 01 Jun 2023 | Sale | 2,750 | 208.7945 | 574,185 | D |
01 Jun 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 01 Jun 2023 | Sale | 400 | 207.01 | 82,804 | D |
07 Jul 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 06 Jul 2023 | Sale | 200 | 218.17 | 43,634 | D |
07 Jul 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 06 Jul 2023 | Sale | 700 | 217.2366 | 152,066 | D |
07 Jul 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 06 Jul 2023 | Sale | 1,187 | 215.5178 | 255,820 | D |
07 Jul 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 06 Jul 2023 | Sale | 3,913 | 214.5786 | 839,646 | D |
15 Jun 2023 17:23 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 15 Jun 2023 | Sale | 2,264 | 228.1951 | 516,634 | D |
15 Jun 2023 17:23 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 15 Jun 2023 | Sale | 3,736 | 227.5162 | 850,001 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)